Vivanza Biosciences Board Approves AGM, MoA/AoA, and Borrowing Limits

Vivanza Biosciences Ltd's Board of Directors met on August 17, 2026, approving key corporate actions. The Board greenlit the Director's Report and Secretarial Audit Report for FY25-26. They also approved convening the 44th Annual General Meeting (AGM) and appointed a scrutinizer for e-voting. A cut-off date of September 4, 2026, was set for AGM eligibility. Furthermore, the Board approved adopting a new Memorandum and Articles of Association, subject to shareholder consent. Proposals to seek member approval for material related party transactions, increased borrowing limits under Section 180(1)(c), and financial transactions under Section 185 were also approved. Additionally, proposals for investments, loans, guarantees, or securities exceeding limits under Section 186 were approved for member consent.